Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4103 | 1770 | 36.1 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2724 | 2763 | AGMATINE//IMIDAZOLINE RECEPTORS//MOXONIDINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AGMATINE | Author keyword | 387 | 71% | 18% | 314 |
2 | IMIDAZOLINE RECEPTORS | Author keyword | 262 | 86% | 8% | 134 |
3 | MOXONIDINE | Author keyword | 187 | 69% | 9% | 158 |
4 | IMIDAZOLINE RECEPTOR | Author keyword | 164 | 82% | 5% | 94 |
5 | RILMENIDINE | Author keyword | 150 | 73% | 7% | 116 |
6 | IMIDAZOLINE BINDING SITES | Author keyword | 79 | 91% | 2% | 32 |
7 | EFAROXAN | Author keyword | 72 | 79% | 3% | 46 |
8 | 2 BFI | Author keyword | 53 | 95% | 1% | 18 |
9 | CLONIDINE DISPLACING SUBSTANCE | Author keyword | 53 | 95% | 1% | 18 |
10 | IMIDAZOLINE BINDING SITE | Author keyword | 45 | 94% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AGMATINE | 387 | 71% | 18% | 314 | Search AGMATINE | Search AGMATINE |
2 | IMIDAZOLINE RECEPTORS | 262 | 86% | 8% | 134 | Search IMIDAZOLINE+RECEPTORS | Search IMIDAZOLINE+RECEPTORS |
3 | MOXONIDINE | 187 | 69% | 9% | 158 | Search MOXONIDINE | Search MOXONIDINE |
4 | IMIDAZOLINE RECEPTOR | 164 | 82% | 5% | 94 | Search IMIDAZOLINE+RECEPTOR | Search IMIDAZOLINE+RECEPTOR |
5 | RILMENIDINE | 150 | 73% | 7% | 116 | Search RILMENIDINE | Search RILMENIDINE |
6 | IMIDAZOLINE BINDING SITES | 79 | 91% | 2% | 32 | Search IMIDAZOLINE+BINDING+SITES | Search IMIDAZOLINE+BINDING+SITES |
7 | EFAROXAN | 72 | 79% | 3% | 46 | Search EFAROXAN | Search EFAROXAN |
8 | 2 BFI | 53 | 95% | 1% | 18 | Search 2+BFI | Search 2+BFI |
9 | CLONIDINE DISPLACING SUBSTANCE | 53 | 95% | 1% | 18 | Search CLONIDINE+DISPLACING+SUBSTANCE | Search CLONIDINE+DISPLACING+SUBSTANCE |
10 | IMIDAZOLINE BINDING SITE | 45 | 94% | 1% | 16 | Search IMIDAZOLINE+BINDING+SITE | Search IMIDAZOLINE+BINDING+SITE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLONIDINE DISPLACING SUBSTANCE | 466 | 88% | 12% | 220 |
2 | H 3 IDAZOXAN | 202 | 84% | 6% | 112 |
3 | RILMENIDINE | 152 | 78% | 6% | 100 |
4 | IMIDAZOLINE RECEPTORS | 134 | 65% | 7% | 129 |
5 | IDAZOXAN BINDING SITES | 109 | 84% | 3% | 59 |
6 | IMIDAZOLINE BINDING SITES | 98 | 79% | 4% | 62 |
7 | MOXONIDINE | 71 | 57% | 5% | 85 |
8 | ALPHA 2 ADRENOCEPTOR ANTAGONIST EFAROXAN | 69 | 96% | 1% | 22 |
9 | I1 IMIDAZOLINE SITES | 69 | 96% | 1% | 22 |
10 | H 3 IDAZOXAN BINDING | 64 | 82% | 2% | 37 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Agmatine: clinical applications after 100 years in translation | 2013 | 17 | 117 | 91% |
'Seeing through a glass darkly': casting light on imidazoline 'I' sites | 1998 | 173 | 67 | 88% |
Agmatine (decarboxylated l-arginine): Physiological role and therapeutic potential | 2012 | 26 | 250 | 86% |
Is agmatine a novel neurotransmitter in brain? | 2000 | 240 | 48 | 79% |
Imidazoline binding sites and their ligands: An overview of the different chemical structures | 2004 | 81 | 90 | 91% |
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites | 2001 | 110 | 239 | 74% |
Imidazoline I-2 receptors: Target for new analgesics? | 2011 | 21 | 83 | 75% |
The pharmacological importance of agmatine in the brain | 2012 | 27 | 212 | 48% |
Imidazoline Antihypertensive Drugs: Selective I1-Imidazoline Receptors Activation | 2012 | 10 | 87 | 92% |
Imidazoline receptors and their endogenous ligands | 1996 | 166 | 137 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROBIOL PHARMACOL CARDIOVASC | 27 | 57% | 1.8% | 32 |
2 | CELLULAR PHARMACOL GRP | 15 | 68% | 0.7% | 13 |
3 | PHARMACOL CARDIOVASC RENALE | 6 | 80% | 0.2% | 4 |
4 | NURSING BIOTECHNOL | 4 | 75% | 0.2% | 3 |
5 | ASSOCIATE UNIT NEUROPHARMACOL | 2 | 67% | 0.1% | 2 |
6 | PHARMACOCHIM MOL SYST MEMBRANAI | 2 | 67% | 0.1% | 2 |
7 | CAJALASSOCIATE UNIT NEUROPHARMACOL | 1 | 50% | 0.1% | 2 |
8 | CSIC CAJALASSOCIATE UNIT | 1 | 50% | 0.1% | 2 |
9 | CSIC NEUROPHARMACOL | 1 | 100% | 0.1% | 2 |
10 | DIPARTIMENTO MED SPERIMENTALE SANITA PUBL | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000146325 | SUBLINGUAL NITROGLYCERIN//SUBLINGUAL GLYCERYL TRINITRATE//BRAIN VASOPRESSIN |
2 | 0.0000139804 | ALPHA2 ADRENOCEPTOR SUBTYPES//ALPHA2 ADRENOCEPTOR SUBTYPE//ALPHA2C ADRENOCEPTOR |
3 | 0.0000105285 | CAS 4205 90 7//CLONIDINE HYDROCHLORIDE//BIOMED PHARM |
4 | 0.0000092450 | 2 IMIDAZOLINE//2 IMIDAZOLINES//BECHAMP REDUCTION |
5 | 0.0000072041 | POSTJUNCTIONAL ALPHA 2 ADRENOCEPTORS//UK14304//ALPHA 1 ADRENOCEPTORS |
6 | 0.0000055560 | CENTPROPAZINE//ISOPRENALINE INDUCED DRINKING//BETA DOWN REGULATION |
7 | 0.0000048655 | RHINITIS MEDICAMENTOSA//TETRAHYDROZOLINE//RHINOSTEREOMETRY |
8 | 0.0000048248 | AFFERENT RENAL NERVES//AFFERENT RENAL NERVE ACTIVITY//RENAL CHEMORECEPTORS |
9 | 0.0000045373 | PIPERAZINE AND PIPERAZIN 1 IUM LIGANDS//ANTIAGGREGATORY ACTIVITIES//PIPERAZINE COMPLEXES |
10 | 0.0000039853 | DEXMEDETOMIDINE//CLONIDINE//SYMPATHETIC NERVOUS SYSTEM DEXMEDETOMIDINE |